1. Home
  2. NBIX vs DOX Comparison

NBIX vs DOX Comparison

Compare NBIX & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • DOX
  • Stock Information
  • Founded
  • NBIX 1992
  • DOX 1982
  • Country
  • NBIX United States
  • DOX United States
  • Employees
  • NBIX N/A
  • DOX N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • DOX EDP Services
  • Sector
  • NBIX Health Care
  • DOX Technology
  • Exchange
  • NBIX Nasdaq
  • DOX Nasdaq
  • Market Cap
  • NBIX 11.6B
  • DOX 10.2B
  • IPO Year
  • NBIX 1996
  • DOX 1998
  • Fundamental
  • Price
  • NBIX $120.69
  • DOX $88.00
  • Analyst Decision
  • NBIX Buy
  • DOX Strong Buy
  • Analyst Count
  • NBIX 21
  • DOX 5
  • Target Price
  • NBIX $168.35
  • DOX $101.20
  • AVG Volume (30 Days)
  • NBIX 1.6M
  • DOX 728.3K
  • Earning Date
  • NBIX 02-06-2025
  • DOX 02-04-2025
  • Dividend Yield
  • NBIX N/A
  • DOX 2.40%
  • EPS Growth
  • NBIX 33.20
  • DOX N/A
  • EPS
  • NBIX 3.29
  • DOX 4.31
  • Revenue
  • NBIX $2,355,300,000.00
  • DOX $4,869,845,000.00
  • Revenue This Year
  • NBIX $16.29
  • DOX N/A
  • Revenue Next Year
  • NBIX $16.90
  • DOX $4.21
  • P/E Ratio
  • NBIX $36.68
  • DOX $20.41
  • Revenue Growth
  • NBIX 24.81
  • DOX N/A
  • 52 Week Low
  • NBIX $110.95
  • DOX $74.41
  • 52 Week High
  • NBIX $157.98
  • DOX $94.04
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 35.76
  • DOX 55.06
  • Support Level
  • NBIX $113.00
  • DOX $85.18
  • Resistance Level
  • NBIX $118.61
  • DOX $90.50
  • Average True Range (ATR)
  • NBIX 4.28
  • DOX 1.95
  • MACD
  • NBIX -2.22
  • DOX 0.22
  • Stochastic Oscillator
  • NBIX 18.81
  • DOX 42.79

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.

Share on Social Networks: